News
A media report stated that an activist investor is accumulating a stake in the Wegovy maker. Wegovy and Ozempic maker Novo ...
In what Guggenheim Partners called one of Metsera’s “critical program milestones” this year, its ultra-long-acting amylin ...
A new analysis shows no clear link between paternal valproate use and harm in offspring, raising questions about the EMA ...
Novo Nordisk Thailand has signed an MoU with HSRI – and the Health Systems Research Institute – to strengthen Thailand’s ...
Novo Nordisk Thailand has signed an MoU with HSRI – and the Health Systems Research Institute – to strengthen Thailand’s clinical research infrastructure and foster healthcare innovation. The ...
Dana Simmons wants you to know that if you are hungry, it is not your fault. In her recently released book, “On Hunger: ...
We recently published a list of Was Jim Cramer Right About These 9 Stocks? In this article, we are going to take a look at ...
Novo Nordisk's (NVO) weight loss drug semaglutide (Ozempic, Wegovy, Rybelsus) is linked to a rare eye condition called NAION ...
Copenhagen celebrates it in August. Maybe for the best, as some major partners withdrew their support for the organization, including Novo Nordisk, Dansk Industri, Google Denmark, or more recently, ...
Novo Nordisk’s stock has tumbled over 50% since its peak around a year ago, and it just ousted its CEO. Former employees say ...
The standard of care for managing patients with type 2 diabetes and CKD -- in addition to a healthy lifestyle -- has always ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results